Loading…
One year in review 2018: systemic lupus erythematosus
Systemic lupus erythematosus (SLE) is a systemic autoimmune condition characterised by a wide spectrum of clinical manifestations, partly related to the disease itself, but also linked to its comorbidities and drugs adverse reactions. Following the previous annual reviews, we focused on new insights...
Saved in:
| Published in: | Clinical and experimental rheumatology 2018-09, Vol.36 (5), p.763-777 |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | |
|---|---|
| cites | |
| container_end_page | 777 |
| container_issue | 5 |
| container_start_page | 763 |
| container_title | Clinical and experimental rheumatology |
| container_volume | 36 |
| creator | Di Battista, Marco Marcucci, Elisa Elefante, Elena Tripoli, Alessandra Governato, Gianmaria Zucchi, Dina Tani, Chiara Alunno, Alessia |
| description | Systemic lupus erythematosus (SLE) is a systemic autoimmune condition characterised by a wide spectrum of clinical manifestations, partly related to the disease itself, but also linked to its comorbidities and drugs adverse reactions. Following the previous annual reviews, we focused on new insights in SLE clinical features, pathogenic pathways, biomarkers of specific organ involvement and therapeutic strategies. We finally concentrated on SLE aspects that could significantly influence patients' quality of life and that need to be investigated in detail through the development and validation of disease-specific patient-reported outcomes. |
| format | article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_2115271155</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2115271155</sourcerecordid><originalsourceid>FETCH-LOGICAL-p211t-d406fd466a1db8fcd5a0018554f2688d5034f9cb6e6c84e01cd4813d4aa12daa3</originalsourceid><addsrcrecordid>eNo1j0tLw0AUhWeh2Fr9CzJLN4F5Z-pOii8odKPgLtzM3GAkSePcjJJ_b8C6OWfz8R3OGVsLvVWFt-59xS6JPoVQzrrygq20UKWyRq-ZPQzIZ4TE24En_G7xhysh_R2nmSbs28C7PGbimObpA3uYjpTpip030BFen3rD3h4fXnfPxf7w9LK73xejknIqohGuicY5kLH2TYgWxOK21jTKeR-t0KbZhtqhC96gkCEaL3U0AFJFAL1ht3_eMR2_MtJU9S0F7DoY8JipWlasKpewC3pzQnPdY6zG1PaQ5ur_qv4FwIxNnw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2115271155</pqid></control><display><type>article</type><title>One year in review 2018: systemic lupus erythematosus</title><source>Freely Accessible Journals</source><creator>Di Battista, Marco ; Marcucci, Elisa ; Elefante, Elena ; Tripoli, Alessandra ; Governato, Gianmaria ; Zucchi, Dina ; Tani, Chiara ; Alunno, Alessia</creator><creatorcontrib>Di Battista, Marco ; Marcucci, Elisa ; Elefante, Elena ; Tripoli, Alessandra ; Governato, Gianmaria ; Zucchi, Dina ; Tani, Chiara ; Alunno, Alessia</creatorcontrib><description>Systemic lupus erythematosus (SLE) is a systemic autoimmune condition characterised by a wide spectrum of clinical manifestations, partly related to the disease itself, but also linked to its comorbidities and drugs adverse reactions. Following the previous annual reviews, we focused on new insights in SLE clinical features, pathogenic pathways, biomarkers of specific organ involvement and therapeutic strategies. We finally concentrated on SLE aspects that could significantly influence patients' quality of life and that need to be investigated in detail through the development and validation of disease-specific patient-reported outcomes.</description><identifier>ISSN: 0392-856X</identifier><identifier>PMID: 30272543</identifier><language>eng</language><publisher>Italy</publisher><subject>Animals ; Biomarkers - metabolism ; Comorbidity ; Disease Progression ; Health Status ; Humans ; Immunosuppressive Agents - therapeutic use ; Lupus Erythematosus, Systemic - diagnosis ; Lupus Erythematosus, Systemic - drug therapy ; Lupus Erythematosus, Systemic - epidemiology ; Lupus Erythematosus, Systemic - immunology ; Predictive Value of Tests ; Quality of Life ; Risk Factors ; Treatment Outcome</subject><ispartof>Clinical and experimental rheumatology, 2018-09, Vol.36 (5), p.763-777</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30272543$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Di Battista, Marco</creatorcontrib><creatorcontrib>Marcucci, Elisa</creatorcontrib><creatorcontrib>Elefante, Elena</creatorcontrib><creatorcontrib>Tripoli, Alessandra</creatorcontrib><creatorcontrib>Governato, Gianmaria</creatorcontrib><creatorcontrib>Zucchi, Dina</creatorcontrib><creatorcontrib>Tani, Chiara</creatorcontrib><creatorcontrib>Alunno, Alessia</creatorcontrib><title>One year in review 2018: systemic lupus erythematosus</title><title>Clinical and experimental rheumatology</title><addtitle>Clin Exp Rheumatol</addtitle><description>Systemic lupus erythematosus (SLE) is a systemic autoimmune condition characterised by a wide spectrum of clinical manifestations, partly related to the disease itself, but also linked to its comorbidities and drugs adverse reactions. Following the previous annual reviews, we focused on new insights in SLE clinical features, pathogenic pathways, biomarkers of specific organ involvement and therapeutic strategies. We finally concentrated on SLE aspects that could significantly influence patients' quality of life and that need to be investigated in detail through the development and validation of disease-specific patient-reported outcomes.</description><subject>Animals</subject><subject>Biomarkers - metabolism</subject><subject>Comorbidity</subject><subject>Disease Progression</subject><subject>Health Status</subject><subject>Humans</subject><subject>Immunosuppressive Agents - therapeutic use</subject><subject>Lupus Erythematosus, Systemic - diagnosis</subject><subject>Lupus Erythematosus, Systemic - drug therapy</subject><subject>Lupus Erythematosus, Systemic - epidemiology</subject><subject>Lupus Erythematosus, Systemic - immunology</subject><subject>Predictive Value of Tests</subject><subject>Quality of Life</subject><subject>Risk Factors</subject><subject>Treatment Outcome</subject><issn>0392-856X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNo1j0tLw0AUhWeh2Fr9CzJLN4F5Z-pOii8odKPgLtzM3GAkSePcjJJ_b8C6OWfz8R3OGVsLvVWFt-59xS6JPoVQzrrygq20UKWyRq-ZPQzIZ4TE24En_G7xhysh_R2nmSbs28C7PGbimObpA3uYjpTpip030BFen3rD3h4fXnfPxf7w9LK73xejknIqohGuicY5kLH2TYgWxOK21jTKeR-t0KbZhtqhC96gkCEaL3U0AFJFAL1ht3_eMR2_MtJU9S0F7DoY8JipWlasKpewC3pzQnPdY6zG1PaQ5ur_qv4FwIxNnw</recordid><startdate>201809</startdate><enddate>201809</enddate><creator>Di Battista, Marco</creator><creator>Marcucci, Elisa</creator><creator>Elefante, Elena</creator><creator>Tripoli, Alessandra</creator><creator>Governato, Gianmaria</creator><creator>Zucchi, Dina</creator><creator>Tani, Chiara</creator><creator>Alunno, Alessia</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>201809</creationdate><title>One year in review 2018: systemic lupus erythematosus</title><author>Di Battista, Marco ; Marcucci, Elisa ; Elefante, Elena ; Tripoli, Alessandra ; Governato, Gianmaria ; Zucchi, Dina ; Tani, Chiara ; Alunno, Alessia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p211t-d406fd466a1db8fcd5a0018554f2688d5034f9cb6e6c84e01cd4813d4aa12daa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Animals</topic><topic>Biomarkers - metabolism</topic><topic>Comorbidity</topic><topic>Disease Progression</topic><topic>Health Status</topic><topic>Humans</topic><topic>Immunosuppressive Agents - therapeutic use</topic><topic>Lupus Erythematosus, Systemic - diagnosis</topic><topic>Lupus Erythematosus, Systemic - drug therapy</topic><topic>Lupus Erythematosus, Systemic - epidemiology</topic><topic>Lupus Erythematosus, Systemic - immunology</topic><topic>Predictive Value of Tests</topic><topic>Quality of Life</topic><topic>Risk Factors</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Di Battista, Marco</creatorcontrib><creatorcontrib>Marcucci, Elisa</creatorcontrib><creatorcontrib>Elefante, Elena</creatorcontrib><creatorcontrib>Tripoli, Alessandra</creatorcontrib><creatorcontrib>Governato, Gianmaria</creatorcontrib><creatorcontrib>Zucchi, Dina</creatorcontrib><creatorcontrib>Tani, Chiara</creatorcontrib><creatorcontrib>Alunno, Alessia</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical and experimental rheumatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Di Battista, Marco</au><au>Marcucci, Elisa</au><au>Elefante, Elena</au><au>Tripoli, Alessandra</au><au>Governato, Gianmaria</au><au>Zucchi, Dina</au><au>Tani, Chiara</au><au>Alunno, Alessia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>One year in review 2018: systemic lupus erythematosus</atitle><jtitle>Clinical and experimental rheumatology</jtitle><addtitle>Clin Exp Rheumatol</addtitle><date>2018-09</date><risdate>2018</risdate><volume>36</volume><issue>5</issue><spage>763</spage><epage>777</epage><pages>763-777</pages><issn>0392-856X</issn><abstract>Systemic lupus erythematosus (SLE) is a systemic autoimmune condition characterised by a wide spectrum of clinical manifestations, partly related to the disease itself, but also linked to its comorbidities and drugs adverse reactions. Following the previous annual reviews, we focused on new insights in SLE clinical features, pathogenic pathways, biomarkers of specific organ involvement and therapeutic strategies. We finally concentrated on SLE aspects that could significantly influence patients' quality of life and that need to be investigated in detail through the development and validation of disease-specific patient-reported outcomes.</abstract><cop>Italy</cop><pmid>30272543</pmid><tpages>15</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0392-856X |
| ispartof | Clinical and experimental rheumatology, 2018-09, Vol.36 (5), p.763-777 |
| issn | 0392-856X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2115271155 |
| source | Freely Accessible Journals |
| subjects | Animals Biomarkers - metabolism Comorbidity Disease Progression Health Status Humans Immunosuppressive Agents - therapeutic use Lupus Erythematosus, Systemic - diagnosis Lupus Erythematosus, Systemic - drug therapy Lupus Erythematosus, Systemic - epidemiology Lupus Erythematosus, Systemic - immunology Predictive Value of Tests Quality of Life Risk Factors Treatment Outcome |
| title | One year in review 2018: systemic lupus erythematosus |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A08%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=One%20year%20in%20review%202018:%20systemic%20lupus%20erythematosus&rft.jtitle=Clinical%20and%20experimental%20rheumatology&rft.au=Di%20Battista,%20Marco&rft.date=2018-09&rft.volume=36&rft.issue=5&rft.spage=763&rft.epage=777&rft.pages=763-777&rft.issn=0392-856X&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E2115271155%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-p211t-d406fd466a1db8fcd5a0018554f2688d5034f9cb6e6c84e01cd4813d4aa12daa3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2115271155&rft_id=info:pmid/30272543&rfr_iscdi=true |